BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36430839)

  • 1. Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Fei F; Zhang M; Tarighat SS; Joo EJ; Yang L; Heisterkamp N
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
    Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia.
    Zhang M; Qi T; Yang L; Kolarich D; Heisterkamp N
    Front Oncol; 2022; 12():828041. PubMed ID: 35371997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.
    Paz H; Joo EJ; Chou CH; Fei F; Mayo KH; Abdel-Azim H; Ghazarian H; Groffen J; Heisterkamp N
    J Exp Clin Cancer Res; 2018 Mar; 37(1):67. PubMed ID: 29580262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.
    Bum-Erdene K; Collins PM; Hugo MW; Tarighat SS; Fei F; Kishor C; Leffler H; Nilsson UJ; Groffen J; Grice ID; Heisterkamp N; Blanchard H
    J Med Chem; 2022 Apr; 65(8):5975-5989. PubMed ID: 35427125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
    Fei F; Joo EJ; Tarighat SS; Schiffer I; Paz H; Fabbri M; Abdel-Azim H; Groffen J; Heisterkamp N
    Oncotarget; 2015 May; 6(13):11378-94. PubMed ID: 25869099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans.
    Suzuki O; Abe M
    Int J Oncol; 2014 May; 44(5):1433-42. PubMed ID: 24589677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The loss of luteal progesterone production in women is associated with a galectin switch via α2,6-sialylation of glycoconjugates.
    Nio-Kobayashi J; Boswell L; Amano M; Iwanaga T; Duncan WC
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4616-24. PubMed ID: 25222756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic binding studies of galectin-1, -3 and -7.
    Brewer CF
    Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
    Luong A; Cerignoli F; Abassi Y; Heisterkamp N; Abdel-Azim H
    PLoS One; 2021; 16(9):e0258140. PubMed ID: 34591931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic galectin-3 and -8 regulate antibacterial autophagy through differential recognition of host glycans on damaged phagosomes.
    Weng IC; Chen HL; Lo TH; Lin WH; Chen HY; Hsu DK; Liu FT
    Glycobiology; 2018 Jun; 28(6):392-405. PubMed ID: 29800364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.
    Stowell SR; Arthur CM; Mehta P; Slanina KA; Blixt O; Leffler H; Smith DF; Cummings RD
    J Biol Chem; 2008 Apr; 283(15):10109-23. PubMed ID: 18216021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-tolerant persister B-cell precursor acute lymphoblastic leukemia cells.
    Zhang M; Yang L; Chen D; Heisterkamp N
    bioRxiv; 2023 Mar; ():. PubMed ID: 36909619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions.
    Bonzi J; Bornet O; Betzi S; Kasper BT; Mahal LK; Mancini SJ; Schiff C; Sebban-Kreuzer C; Guerlesquin F; Elantak L
    Nat Commun; 2015 Feb; 6():6194. PubMed ID: 25708191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7.
    Lohr M; Kaltner H; Lensch M; André S; Sinowatz F; Gabius HJ
    Histochem Cell Biol; 2008 Sep; 130(3):567-81. PubMed ID: 18597104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-9 binds to O-glycans on protein disulfide isomerase.
    Schaefer K; Webb NE; Pang M; Hernandez-Davies JE; Lee KP; Gonzalez P; Douglass MV; Lee B; Baum LG
    Glycobiology; 2017 Sep; 27(9):878-887. PubMed ID: 28810662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the glycophenotype of squamous epithelia using plant and mammalian lectins. Differentiation-dependent expression of alpha2,6- and alpha2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas, and its differential effect on binding of the endogenous lectins galectins-1 and -3.
    Holíková Z; Hrdlicková-Cela E; Plzák J; Smetana K; Betka J; Dvoránková B; Esner M; Wasano K; André S; Kaltner H; Motlík J; Hercogová J; Kodet R; Gabius HJ
    APMIS; 2002 Dec; 110(12):845-56. PubMed ID: 12645662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.